The β
Humans
Antigens
/ immunology
Catecholamines
/ metabolism
CD8-Positive T-Lymphocytes
/ cytology
Cell Proliferation
Immune Checkpoint Inhibitors
/ therapeutic use
Melanoma
/ immunology
Memory T Cells
/ cytology
Pancreatic Neoplasms
/ immunology
Receptors, Adrenergic, beta-1
/ metabolism
Sympathetic Nervous System
/ immunology
T-Cell Exhaustion
Stress, Physiological
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
26
09
2022
accepted:
24
08
2023
medline:
23
10
2023
pubmed:
21
9
2023
entrez:
21
9
2023
Statut:
ppublish
Résumé
CD8
Identifiants
pubmed: 37731001
doi: 10.1038/s41586-023-06568-6
pii: 10.1038/s41586-023-06568-6
doi:
Substances chimiques
ADRB1 protein, human
0
Antigens
0
Catecholamines
0
Immune Checkpoint Inhibitors
0
Receptors, Adrenergic, beta-1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
383-392Subventions
Organisme : NCI NIH HHS
ID : K00 CA222741
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Amezquita, R. A. & Kaech, S. M. Immunology: the chronicles of T-cell exhaustion. Nature 543, 190–191 (2017).
pubmed: 28225757
doi: 10.1038/nature21508
Xie, H. et al. Association of increased circulating catecholamine and glucocorticoid levels with risk of psychological problems in oral neoplasm patients. PLoS ONE 9, e99179 (2014).
pubmed: 25048798
pmcid: 4105410
doi: 10.1371/journal.pone.0099179
Bastos, D. B. et al. Circulating catecholamines are associated with biobehavioral factors and anxiety symptoms in head and neck cancer patients. PLoS ONE 13, e0202515 (2018).
pubmed: 30125310
pmcid: 6101398
doi: 10.1371/journal.pone.0202515
Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).
pubmed: 26205583
pmcid: 4889009
doi: 10.1038/nri3862
Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265–269 (2019).
pubmed: 31207605
doi: 10.1038/s41586-019-1326-9
Khan, O. et al. TOX transcriptionally and epigenetically programs CD8
pubmed: 31207603
pmcid: 6713202
doi: 10.1038/s41586-019-1325-x
Paley, M. A. et al. Progenitor and terminal subsets of CD8
pubmed: 23197535
pmcid: 3653769
doi: 10.1126/science.1229620
Im, S. J. et al. Defining CD8
pubmed: 27501248
pmcid: 5297183
doi: 10.1038/nature19330
Miller, B. C. et al. Subsets of exhausted CD8
pubmed: 30778252
pmcid: 6673650
doi: 10.1038/s41590-019-0312-6
Hudson, W. H. et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1
pubmed: 31810882
pmcid: 6920571
doi: 10.1016/j.immuni.2019.11.002
Raju, S. et al. Identification of a T-bet
pubmed: 34088768
doi: 10.4049/jimmunol.2001348
Zehn, D., Thimme, R., Lugli, E., de Almeida, G. P. & Oxenius, A. ‘Stem-like’ precursors are the fount to sustain persistent CD8
pubmed: 35624209
doi: 10.1038/s41590-022-01219-w
Chung, H. K., McDonald, B. & Kaech, S. M. The architectural design of CD8
Chen, Y. et al. BATF regulates progenitor to cytolytic effector CD8
pubmed: 34282329
pmcid: 9258987
doi: 10.1038/s41590-021-00965-7
Kasmani, M. Y. et al. Clonal lineage tracing reveals mechanisms skewing CD8
Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350–1355 (2018).
pubmed: 29567705
pmcid: 7391259
doi: 10.1126/science.aar4060
Schmiechen, Z. C. & Stromnes, I. M. Mechanisms governing immunotherapy resistance in pancreatic ductal adenocarcinoma. Front. Immunol. 11, 613815 (2020).
pubmed: 33584701
doi: 10.3389/fimmu.2020.613815
Mueller, S. N. Neural control of immune cell trafficking. J. Exp. Med. https://doi.org/10.1084/jem.20211604 (2022).
Devi, S. et al. Adrenergic regulation of the vasculature impairs leukocyte interstitial migration and suppresses immune responses. Immunity 54, 1219–1230.e7 (2021).
pubmed: 33915109
doi: 10.1016/j.immuni.2021.03.025
Grebe, K. M. et al. Sympathetic nervous system control of anti-influenza CD8
pubmed: 19286971
pmcid: 2664017
doi: 10.1073/pnas.0808851106
Sanders, V. M. et al. Differential expression of the β
pubmed: 9126981
doi: 10.4049/jimmunol.158.9.4200
Daher, C. et al. Blockade of β-adrenergic receptors improves CD8
pubmed: 31527069
doi: 10.1158/2326-6066.CIR-18-0833
Felten, S. Y. & Olschowka, J. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 18, 37–48 (1987).
pubmed: 2890771
doi: 10.1002/jnr.490180108
Giles, J. R. et al. Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers. Immunity 55, 557–574.e7 (2022).
pubmed: 35263570
pmcid: 9214622
doi: 10.1016/j.immuni.2022.02.004
Sassone-Corsi, P. The cyclic AMP pathway. Cold Spring Harb. Perspect. Biol. https://doi.org/10.1101/cshperspect.a011148 (2012).
Maine, C. J., Teijaro, J. R., Marquardt, K. & Sherman, L. A. PTPN22 contributes to exhaustion of T lymphocytes during chronic viral infection. Proc. Natl Acad. Sci. USA 113, e7231–e7239 (2016).
pubmed: 27799548
pmcid: 5135306
doi: 10.1073/pnas.1603738113
Sandu, I., Cerletti, D., Claassen, M. & Oxenius, A. Exhausted CD8
pubmed: 32901001
pmcid: 7479152
doi: 10.1038/s41467-020-18256-4
Staron, M. M. et al. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8
pubmed: 25464856
pmcid: 4270830
doi: 10.1016/j.immuni.2014.10.013
Riley, J. L. PD-1 signaling in primary T cells. Immunol. Rev. 229, 114–125 (2009).
pubmed: 19426218
pmcid: 3424066
doi: 10.1111/j.1600-065X.2009.00767.x
Aandahl, E. M. et al. Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients. FASEB J. 12, 855–862 (1998).
pubmed: 9657525
doi: 10.1096/fasebj.12.10.855
Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8
pubmed: 17723218
pmcid: 2034442
doi: 10.1016/j.immuni.2007.07.010
Sarkar, S. et al. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205, 625–640 (2008).
pubmed: 18316415
pmcid: 2275385
doi: 10.1084/jem.20071641
Gerlach, C. et al. The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T cell subsets with distinct roles in immune surveillance and homeostasis. Immunity 45, 1270–1284 (2016).
pubmed: 27939671
pmcid: 5177508
doi: 10.1016/j.immuni.2016.10.018
Gorre, F. & Vandekerckhove, H. Beta-blockers: focus on mechanism of action. Which beta-blocker, when and why? Acta Cardiol. 65, 565–570 (2010).
pubmed: 21125979
doi: 10.1080/AC.65.5.2056244
Baker, J. G. The selectivity of β-adrenoceptor antagonists at the human β
pubmed: 15655528
pmcid: 1576008
doi: 10.1038/sj.bjp.0706048
Rawla, P., Sunkara, T. & Gaduputi, V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J. Oncol. 10, 10–27 (2019).
pubmed: 30834048
pmcid: 6396775
doi: 10.14740/wjon1166
Woods, S. C. & Porte, D. Jr Neural control of the endocrine pancreas. Physiol. Rev. 54, 596–619 (1974).
pubmed: 4601624
doi: 10.1152/physrev.1974.54.3.596
Bayne, L. J. et al. Tumor-derived granulocyte–macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21, 822–835 (2012).
pubmed: 22698406
pmcid: 3575028
doi: 10.1016/j.ccr.2012.04.025
Stromnes, I. M. et al. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity. Gut 63, 1769–1781 (2014).
pubmed: 24555999
doi: 10.1136/gutjnl-2013-306271
Mohammadpour, H. et al. β
pubmed: 31566578
pmcid: 6877316
doi: 10.1172/JCI129502
Kokolus, K. M. et al. Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. Oncoimmunology 7, e1405205 (2018).
pubmed: 29399407
doi: 10.1080/2162402X.2017.1405205
Gandhi, S. et al. Phase I clinical trial of combination propranolol and pembrolizumab in locally advanced and metastatic melanoma: safety, tolerability, and preliminary evidence of antitumor activity. Clin. Cancer Res. 27, 87–95 (2021).
pubmed: 33127652
doi: 10.1158/1078-0432.CCR-20-2381
Fjæstad, K. Y. et al. Blockade of β-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment. Oncogene 41, 1364–1375 (2022).
pubmed: 35017664
pmcid: 8881216
doi: 10.1038/s41388-021-02170-0
Ganesan, A. P. et al. Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nat. Immunol. 18, 940–950 (2017).
pubmed: 28628092
pmcid: 6036910
doi: 10.1038/ni.3775
Milner, J. J. et al. Runx3 programs CD8
pubmed: 29211713
pmcid: 5747964
doi: 10.1038/nature24993
Banchereau, R. et al. Intratumoral CD103
Kennedy, O. J. et al. Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma. Eur. J. Cancer 165, 97–112 (2022).
pubmed: 35220182
doi: 10.1016/j.ejca.2022.01.017
Udumyan, R. et al. Beta-blocker drug use and survival among patients with pancreatic adenocarcinoma. Cancer Res. 77, 3700–3707 (2017).
pubmed: 28473530
doi: 10.1158/0008-5472.CAN-17-0108
Beg, M. S. et al. Impact of concurrent medication use on pancreatic cancer survival—SEER–Medicare analysis. Am. J. Clin. Oncol. 41, 766–771 (2018).
pubmed: 28079594
pmcid: 5503814
doi: 10.1097/COC.0000000000000359
Wherry, E. J. et al. Molecular signature of CD8
pubmed: 17950003
doi: 10.1016/j.immuni.2007.09.006
Pircher, H., Bürki, K., Lang, R., Hengartner, H. & Zinkernagel, R. M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342, 559–561 (1989).
pubmed: 2573841
doi: 10.1038/342559a0
Wang, J. et al. UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model. Pigment Cell Melanoma Res. 30, 428–435 (2017).
pubmed: 28379630
pmcid: 5820096
doi: 10.1111/pcmr.12591
Li, J. et al. Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy. Immunity 49, 178–193.e7 (2018).
pubmed: 29958801
pmcid: 6707727
doi: 10.1016/j.immuni.2018.06.006
Nüssing, S. et al. Efficient CRISPR/Cas9 gene editing in uncultured naive mouse T cells for in vivo studies. J. Immunol. 204, 2308–2315 (2020).
pubmed: 32152070
doi: 10.4049/jimmunol.1901396
Lun, A. T., McCarthy, D. J. & Marioni, J. C. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Research 5, 2122 (2016).
pubmed: 27909575
pmcid: 5112579
Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163–172 (2019).
pubmed: 30643263
pmcid: 6340744
doi: 10.1038/s41590-018-0276-y
van Dijk, D. et al. Recovering gene interactions from single-cell data using data diffusion. Cell 174, 716–729.e27 (2018).
pubmed: 29961576
pmcid: 6771278
doi: 10.1016/j.cell.2018.05.061
Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849 (2016).
pubmed: 27207943
doi: 10.1093/bioinformatics/btw313
Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083–1086 (2017).
pubmed: 28991892
pmcid: 5937676
doi: 10.1038/nmeth.4463
Andreatta, M. & Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. Comput. Struct. Biotechnol. J. 19, 3796–3798 (2021).
pubmed: 34285779
pmcid: 8271111
doi: 10.1016/j.csbj.2021.06.043
Radtke, A. J. et al. IBEX: an iterative immunolabeling and chemical bleaching method for high-content imaging of diverse tissues. Nat. Protoc. 17, 378–401 (2022).
pubmed: 35022622
doi: 10.1038/s41596-021-00644-9
Radtke, A. J. et al. IBEX: a versatile multiplex optical imaging approach for deep phenotyping and spatial analysis of cells in complex tissues. Proc. Natl Acad. Sci. USA 117, 33455–33465 (2020).
pubmed: 33376221
pmcid: 7776876
doi: 10.1073/pnas.2018488117
Schalper, K. A. et al. Objective measurement and clinical significance of TILs in non-small cell lung cancer. J. Natl Cancer Inst. 107, dju435 (2015).
pubmed: 25650315
pmcid: 4565530
doi: 10.1093/jnci/dju435